Nutex Health (NUTX) Competitors $111.91 +1.13 (+1.02%) As of 01:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUTX vs. PAYO, RNG, EVTC, APLD, RAMP, FIVN, DFIN, PLTK, PINC, and GDRXShould you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include Payoneer Global (PAYO), Ringcentral (RNG), Evertec (EVTC), Applied Digital (APLD), LiveRamp (RAMP), Five9 (FIVN), Donnelley Financial Solutions (DFIN), Playtika (PLTK), Premier (PINC), and GoodRx (GDRX). These companies are all part of the "business services" industry. Nutex Health vs. Its Competitors Payoneer Global Ringcentral Evertec Applied Digital LiveRamp Five9 Donnelley Financial Solutions Playtika Premier GoodRx Payoneer Global (NASDAQ:PAYO) and Nutex Health (NASDAQ:NUTX) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation. Which has preferable valuation and earnings, PAYO or NUTX? Payoneer Global has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Payoneer Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPayoneer Global$977.72M2.51$121.16M$0.3022.65Nutex Health$479.95M1.31$52.18M$11.899.51 Is PAYO or NUTX more profitable? Payoneer Global has a net margin of 11.32% compared to Nutex Health's net margin of 10.76%. Nutex Health's return on equity of 42.08% beat Payoneer Global's return on equity.Company Net Margins Return on Equity Return on Assets Payoneer Global11.32% 15.70% 1.53% Nutex Health 10.76%42.08%11.80% Which has more risk & volatility, PAYO or NUTX? Payoneer Global has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500. Does the media refer more to PAYO or NUTX? In the previous week, Payoneer Global and Payoneer Global both had 5 articles in the media. Payoneer Global's average media sentiment score of 0.91 beat Nutex Health's score of 0.46 indicating that Payoneer Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Payoneer Global 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nutex Health 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend PAYO or NUTX? Payoneer Global currently has a consensus price target of $9.81, indicating a potential upside of 44.41%. Nutex Health has a consensus price target of $262.50, indicating a potential upside of 132.25%. Given Nutex Health's higher probable upside, analysts clearly believe Nutex Health is more favorable than Payoneer Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Payoneer Global 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00Nutex Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in PAYO or NUTX? 82.2% of Payoneer Global shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 2.6% of Payoneer Global shares are owned by company insiders. Comparatively, 36.9% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryPayoneer Global beats Nutex Health on 10 of the 15 factors compared between the two stocks. Get Nutex Health News Delivered to You Automatically Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUTX vs. The Competition Export to ExcelMetricNutex HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$630.95M$6.85B$5.52B$9.42BDividend YieldN/A2.87%3.80%4.06%P/E Ratio9.5426.8728.0919.89Price / Sales1.3136.84446.52102.31Price / Cash7.9026.7235.8457.94Price / Book3.049.048.185.68Net Income$52.18M$233.10M$3.24B$257.97M7 Day Performance-1.38%0.28%1.80%2.51%1 Month Performance-5.02%1.86%8.25%11.64%1 Year Performance1,581.92%24.18%30.50%18.87% Nutex Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUTXNutex Health2.6544 of 5 stars$111.91+1.0%$262.50+134.6%+1,588.7%$622.22M$479.95M9.411,150PAYOPayoneer Global4.4245 of 5 stars$6.94+7.1%$10.44+50.4%+24.5%$2.51B$996.15M23.132,407Analyst ForecastRNGRingcentral4.6845 of 5 stars$26.53-1.5%$33.08+24.7%-18.9%$2.39B$2.43B-60.304,260Positive NewsEVTCEvertec3.1495 of 5 stars$34.15+0.9%$40.00+17.1%-2.7%$2.17B$845.49M17.164,800News CoverageAnalyst ForecastAPLDApplied Digital2.7139 of 5 stars$9.52+3.7%$12.73+33.7%+76.0%$2.14B$165.57M-6.95121Options VolumeAnalyst RevisionGap UpRAMPLiveRamp3.8486 of 5 stars$32.60+1.4%$41.29+26.7%+3.0%$2.12B$745.58M-3,259.501,300FIVNFive93.922 of 5 stars$26.21-1.5%$42.05+60.4%-42.4%$2.00B$1.04B-291.193,073Positive NewsOptions VolumeDFINDonnelley Financial Solutions2.3173 of 5 stars$63.41-1.4%$71.33+12.5%-4.8%$1.75B$781.90M21.001,800Positive NewsPLTKPlaytika4.3024 of 5 stars$4.67-1.1%$7.68+64.4%-41.9%$1.75B$2.55B12.293,500PINCPremier1.9479 of 5 stars$21.25+0.8%$22.20+4.5%+6.5%$1.75B$1.35B37.282,900News CoveragePositive NewsGDRXGoodRx2.9792 of 5 stars$4.83+1.9%$6.55+35.5%-42.7%$1.73B$792.32M60.38950 Related Companies and Tools Related Companies Payoneer Global Alternatives Ringcentral Alternatives Evertec Alternatives Applied Digital Alternatives LiveRamp Alternatives Five9 Alternatives Donnelley Financial Solutions Alternatives Playtika Alternatives Premier Alternatives GoodRx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUTX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMiss This Window And You Miss EverythingThere’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the ph...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutex Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
